FDA clears nerve stimulator to aid recovery from opioids

November 15, 2017
This photo provided by Innovative Health Solutions shows the NSS-2 Bridge. On Wednesday, Nov. 15, 2017, the Food and Drug Administration announced clearance of the NSS-2 Bridge, a brain-stimulating device for patients suffering from debilitating withdrawal symptoms caused by addiction to heroin and other opioids. The nerve stimulator is the first device to treat such symptoms including joint pain, anxiety, stomach aches and insomnia. (Courtesy of Innovative Health Solutions, Inc. via AP)

U.S. health authorities have cleared a brain-stimulating device for patients suffering from debilitating withdrawal symptoms caused by addiction to heroin and other opioids.

The nerve stimulator is the first device to treat such symptoms including joint pain, anxiety, stomach aches and insomnia. The announcement Wednesday by the Food and Drug Administration comes amid an epidemic of opioid abuse, which includes both illegal narcotics like heroin and prescription painkillers.

The device, known as NSS-2 Bridge, is worn behind the ear where several electrodes stimulate nerves in the brain and spinal cord to relieve symptoms. The FDA says a study of more than 70 patients showed a 30 percent decrease in symptoms within 30 minutes of using the device.

Nerve stimulators have previously been approved to treat epilepsy and depression.

FDA clears nerve stimulator to aid recovery from opioids
This photo provided by Innovative Health Solutions shows the NSS-2 Bridge. On Wednesday, Nov. 15, 2017, the Food and Drug Administration announced clearance of the NSS-2 Bridge, a brain-stimulating device for patients suffering from debilitating withdrawal symptoms caused by addiction to heroin and other opioids. The nerve stimulator is the first device to treat such symptoms including joint pain, anxiety, stomach aches and insomnia. (Courtesy of Innovative Health Solutions, Inc. via AP)

Explore further: Fentanyl in more than half of opioid deaths in 10 states

Related Stories

Fentanyl in more than half of opioid deaths in 10 states

October 27, 2017
A federal report says the powerful painkiller fentanyl was involved in more than half of the recent opioid overdose deaths in 10 states.

FDA approves first drug-oozing implant to control addiction

May 26, 2016
Federal health officials on Thursday approved an innovative new option for Americans struggling with addiction to heroin and painkillers: a drug-oozing implant that curbs craving and withdrawal symptoms for six months at ...

Strategies to combat the opioid epidemic

November 15, 2017
The opioid epidemic is ravaging lives and tearing families apart. Overdose deaths from heroin, fentanyl and misused prescription painkillers have tripled in the past 15 years. Chemical & Engineering News, the weekly newsmagazine ...

The path from prescription painkillers to addiction

February 26, 2016
Abuse of prescription painkillers has become an epidemic in the United States, according to the Centers for Disease Control and Prevention. Even more concerning is that those going through withdrawal may turn to heroin as ...

CDC launches opioid campaign in hard-hit states

September 26, 2017
(HealthDay)—The U. S. Centers for Disease Control and Prevention has launched a campaign to reduce overdose deaths from prescription opioid painkillers.

Spinal cord stimulation relieves back pain without opioids

March 23, 2017
Doctors who treat patients suffering from back pain are exploring new approaches that help some patients avoid opioid drugs. The highly addictive prescription painkillers are fueling an epidemic of abuse and overdose deaths.

Recommended for you

Novel botulinum toxin compound relieves chronic pain

July 18, 2018
A modified form of botulinum toxin gives long-lasting pain relief in mice without adverse effects and, in time, could replace opioid drugs as a safe and effective way of treating chronic pain, according to research by UCL, ...

FDA recalls heart medication valsartan, citing cancer concerns

July 17, 2018
The U.S. Food and Drug Administration issued a voluntary recall of several medications that contain the active ingredient valsartan, which is used to treat high blood pressure and heart failure.

Opioids given too easily to children: study

July 16, 2018
(HealthDay)—Many children are prescribed powerful opioid painkillers they don't really need, putting them and those around them at risk, a new study shows.

Study reveals opioid patients face multiple barriers to treatment

July 12, 2018
In areas of the country disproportionately affected by the opioid crisis, treatment programs are less likely to accept patients paying through insurance of any type or accept pregnant women, a new Vanderbilt study found.

Report details possible conflict of interest issues for FDA advisors

July 6, 2018
Charles Piller, a contributing correspondent for the journal Science, has published a Feature piece in the journal detailing what he describes as possible conflicts of interest issues by people who serve as advisors to the ...

Opioid epidemic responses overlook gender

July 5, 2018
Yale health experts warn that current efforts to confront the growth of opioid addiction and overdose deaths must better incorporate an understanding of how women fit into this epidemic.

1 comment

Adjust slider to filter visible comments by rank

Display comments: newest first

Captain Stumpy
not rated yet Nov 26, 2017
@bubba the pseudoscience FRAUD
Quackery
at least you are honest about labeling your claim as being quackery

1- opioid addiction cannot be treated with your pseudoscience psychotropic bullsh*t

2- fraudulently attempting to prescribe a psychotropic without a license is illegal in your state (controlled by FED and State law)

3- " there is no robust bioassay-led evidence for the widely published claims that four steroid molecules are human pheromones"
http://rspb.royal...full.pdf

reported

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.